Shiny K. Kajal/LinkedIn
Mar 3, 2026, 17:04
Shiny K Kajal: Therapeutic Apheresis Is Redefining the Clinical Scope of Transfusion Medicine
Shiny K Kajal, Senior Resident at Adesh University, shared a post on LinkedIn:
“Post 29 – When most people think of transfusion medicine, they think of blood bags and compatibility testing.
But modern Immunohematology and Blood Transfusion goes far beyond that.
Therapeutic Apheresis allows selective removal of disease-causing components directly from circulation – offering rapid clinical benefit in several critical conditions.
Key Apheresis Modalities
- Therapeutic Plasma Exchange (TPE) – Removal of pathogenic plasma components
- Red Cell Exchange – Replacement of abnormal erythrocytes
- Leukapheresis – Rapid cytoreduction in leukocytosis
- Plateletpheresis – Control of extreme thrombocytosis
- LDL Apheresis – Removal of atherogenic lipoproteins
From autoimmune diseases to hematologic emergencies, therapeutic apheresis is redefining the clinical scope of transfusion medicine.
Not just transfusing blood — but therapeutically transforming it.”
Stay updated with Hemostasis Today.
-
Sep 10, 2026, 05:12Douglas S. Campbell: Great to See a Strong Japanese Presence in 2026 Lasker Awards
-
Sep 10, 2026, 05:11Jan Hartmann: New Transformative Treatment for Hemophilia A
-
Sep 10, 2026, 05:09Shelby Bradford: Award-Winning Science Incoming
-
Sep 9, 2026, 17:57CRISPR/Cas Gene Editing in β-Thalassemia: From Molecular Correction to Clinical Reality
-
Sep 9, 2026, 17:38Cardiovascular Health in Bleeding Disorders – EHC
-
Sep 9, 2026, 17:33Manasvi Shah: Co-Inheritance of Alpha Globin Gene Multiplication With Beta Globin Gene Abnormalities
-
Sep 9, 2026, 17:29Christina Crossette-Thambiah: One of the Largest Studies to Date in Antiphospholipid Syndrome
-
Sep 9, 2026, 17:25Alan Nurden: A miR-146a Variant Reveals a New Pathway Linking Platelet Metabolism and Thrombosis
-
Sep 9, 2026, 17:17When Is Thrombophilia Testing Appropriate and How Can the Evidence Guide Clinical Care? – ISTH